Organogenesis wins grant for bioartificial liver:
This article was originally published in Clinica
Organogenesis is to develop a bioartificial liver using a $2 million award from the US National Institute for Standards and Technology. The liver assist device, which uses living liver cells housed in cartridges outside the body, could replace the need for transplantation by providing minimally invasive, short-term support until the patient's own liver recovers or until a transplantable liver becomes available, said the Canton, Massachusetts-based company.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.